AnalystsMaxwell SkorMaxwell Skor's Stock Forecasts
AnalystsMaxwell Skor
Sectors:
Industries:
Analyst Ranking
Top 35%
#1824 out of 5290 analysts
Average Return
+33.42%
Win Rate
43%3 out of 7
Risk vs Reward
Poor
Good
Maxwell Skor's 5 best and worst ratings
Maxwell Skor Analyst Color
Get additional color on Maxwell Skor's coverage of popular stocks
Maxwell Skor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | 1 | Strong Buy | $115.00 | +92.92% | Initiates Coverage On | 5 months ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $190.00 | -14.17% | Initiates Coverage On | 8 months ago |
Insmed IncINSM | 1 | Hold | $144.00 | +37.25% | Maintains | 9 months ago |
Ascendis Pharma AASND | 1 | Strong Buy | $250.00 | +14.24% | Assumes | a year ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $12.00 | +305.41% | Assumes | a year ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $10.00 | N/A | Assumes | a year ago |
Invivyd IncIVVD | 2 | Strong Buy | $3.55 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.